Viral vector-based prime-boost immunization regimens: A possible involvement of T-cell competition

Gene Therapy

Volumn 15, Issue 6, 2008, Pages 393-403

  de Mare, A ^a   Lambeck, A J A ^a   Regts, J ^a   van Dam, G M ^a   Nijman, H W ^a   Snippe, H ^b   Wilschut, J ^a   Daemen, T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

E6E7 HYBRID PROTEIN; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; SEMLIKI FOREST ALPHAVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IMMUNOMODULATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIBODIES, MONOCLONAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; LUCIFERASES; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; SEMLIKI FOREST VIRUS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES; VACCINES, SYNTHETIC; VIRAL VACCINES; VIROSOMES;

HUMAN PAPILLOMAVIRUS; MUS; RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS;

EID: 40249118462     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303060     Document Type: Article

References (48)